Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALDX |
---|---|---|
09:32 ET | 2784 | 5.44 |
09:34 ET | 7521 | 5.395 |
09:36 ET | 1876 | 5.48 |
09:38 ET | 3131 | 5.53 |
09:39 ET | 200 | 5.5 |
09:41 ET | 200 | 5.51 |
09:43 ET | 1707 | 5.51 |
09:45 ET | 13511 | 5.58 |
09:48 ET | 11760 | 5.5405 |
09:50 ET | 150 | 5.5444 |
09:52 ET | 6119 | 5.53 |
09:54 ET | 21662 | 5.57 |
09:56 ET | 2030 | 5.54 |
09:57 ET | 7100 | 5.49 |
09:59 ET | 300 | 5.49 |
10:01 ET | 3249 | 5.495 |
10:03 ET | 624 | 5.5 |
10:06 ET | 1100 | 5.5 |
10:08 ET | 4218 | 5.5 |
10:10 ET | 1448 | 5.51 |
10:12 ET | 11805 | 5.51 |
10:14 ET | 100 | 5.49 |
10:15 ET | 100 | 5.495 |
10:17 ET | 8744 | 5.48 |
10:19 ET | 430 | 5.485 |
10:21 ET | 822 | 5.5 |
10:24 ET | 1200 | 5.5 |
10:28 ET | 200 | 5.5 |
10:30 ET | 925 | 5.525 |
10:32 ET | 1528 | 5.5 |
10:33 ET | 300 | 5.5 |
10:35 ET | 498 | 5.51 |
10:37 ET | 917 | 5.52 |
10:39 ET | 1117 | 5.52 |
10:42 ET | 1370 | 5.5 |
10:44 ET | 608 | 5.51 |
10:46 ET | 901 | 5.54 |
10:48 ET | 1326 | 5.54 |
10:50 ET | 500 | 5.53 |
10:51 ET | 500 | 5.53 |
10:53 ET | 5611 | 5.54 |
10:55 ET | 32859 | 5.56 |
10:57 ET | 2449 | 5.58 |
11:00 ET | 3354 | 5.625 |
11:02 ET | 825 | 5.625 |
11:06 ET | 1117 | 5.63 |
11:08 ET | 5182 | 5.64 |
11:09 ET | 1877 | 5.64 |
11:11 ET | 400 | 5.64 |
11:13 ET | 3402 | 5.63 |
11:15 ET | 545 | 5.63 |
11:18 ET | 2147 | 5.67 |
11:22 ET | 900 | 5.62 |
11:24 ET | 600 | 5.635 |
11:26 ET | 1018 | 5.61 |
11:27 ET | 2800 | 5.5998 |
11:29 ET | 100 | 5.6 |
11:31 ET | 230 | 5.6 |
11:33 ET | 100 | 5.6 |
11:36 ET | 400 | 5.61 |
11:38 ET | 800 | 5.6 |
11:40 ET | 100 | 5.585 |
11:42 ET | 402 | 5.595 |
11:44 ET | 552 | 5.61 |
11:45 ET | 800 | 5.595 |
11:47 ET | 2593 | 5.6 |
11:49 ET | 1005 | 5.59 |
11:51 ET | 10540 | 5.575 |
11:56 ET | 200 | 5.585 |
11:58 ET | 400 | 5.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aldeyra Therapeutics Inc | 319.1M | -8.8x | --- |
Corvus Pharmaceuticals Inc | 318.4M | -11.7x | --- |
Inozyme Pharma Inc | 322.5M | -3.6x | --- |
Korro Bio Inc | 323.1M | -1.2x | --- |
Nkarta Inc | 323.2M | -2.3x | --- |
Alto Neuroscience Inc | 323.5M | --- | --- |
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of proliferative vitreoretinopathy and retinitis pigmentosa. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its preclinical RASP platform includes ADX-246 and ADX-248 in development for metabolic, retinal diseases and systemic inflammatory diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $319.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-0.64 |
Book Value | $2.02 |
P/E Ratio | -8.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.